BAJAJ BROKING
Mankind Pharma pledged 56.31% of its shares in Bharat Serums for ₹5,000 crore NCDs. Mankind Pharma share price rose 1%, settling at ₹2,918.55, with a 46% one-year return.
Mankind Pharma has pledged an additional 56.31% equity shares of Bharat Serums and Vaccines Ltd (BSV), its wholly owned subsidiary, in favour of Catalyst Trusteeship Ltd. This move secures its listed, rated, and redeemable non-convertible debentures (NCDs) worth ₹5,000 crore, issued in three series. The pledge strengthens the security framework for NCD holders and demonstrates Mankind Pharma’s commitment to meeting its financial obligations.
Also read: M&M unveils BE 6 and XEV 9e Pack Three at ₹26.9 lakh and ₹30.5 lakh
Equity pledged: 56.31% of BSV shares
Subsidiary: Bharat Serums and Vaccines Ltd (BSV)
NCD value: ₹5,000 crore
Debenture trust deeds date: 10 October 2024
Trustee: Catalyst Trusteeship Ltd
Also read: Tata Steel reports 6.17% rise in India’s steel production in Q3FY25
Catalyst Trusteeship Ltd acts as the Common Security Trustee for the NCD holders, ensuring that the pledged equity serves as collateral for the debentures. This arrangement is part of the agreements executed in October 2024, highlighting Mankind Pharma’s strategic approach to managing its financial instruments.
Mankind Pharma continues to deliver strong market performance. The Mankind Pharma share price rose by over 1% to ₹2,918.55 on the BSE. The company’s stock has provided a one-year return of nearly 46%, reflecting investor confidence in its growth trajectory.
Parameter | Details |
NCD Value | ₹5,000 crore |
Number of Series | 3 |
Trustee | Catalyst Trusteeship Ltd |
Equity Pledged | 56.31% of BSV shares |
Debenture Deed Date | 10 October 2024 |
The Mankind Pharma share price has shown resilience, reflecting positive sentiment in the market. With a 46% one-year return, the stock has outperformed expectations, underscoring the company’s robust financial position and strategic moves.
Mankind Pharma’s pledge of additional equity in Bharat Serums strengthens its financial security and showcases its commitment to fulfilling NCD-related obligations.
Also read: NTPC enters nuclear energy business with NPUNL incorporation
Do you have a trading account app or demat account app?
You can open an account with Bajaj Broking in minutes.
Download the Bajaj Broking app now from Play Store or App Store.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading